TradingMenu expanded
Forge Markets Forge Pro Browse Companies
DataMenu expanded
Forge Data Private Market Index Forge Accuidity Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News Tech IPO Calendar for 2024
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Forge Pro
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
Forge Accuidity Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
Tech IPO Calendar for 2024
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / SURGE Therapeutics Stock

SURGE Therapeutics Stock

www.surgetx.com/Healthcare / BioTech & PharmaFounded: 2016

SURGE, The Intraoperative Immunotherapy Company™, envisions a world where all cancer patients undergoing tumor resection receive intraoperative immunotherapy to prevent recurrence and metastasis. Aiming to change the standard of care, SURGE focuses on transforming the deployment of cancer immunotherapy to improve survival outcomes dramatically. Their approach is dedicated to delivering focused immunotherapy treatments, redefining how, when, and where they are administered to cancer patients.

Buy or sell SURGE Therapeutics stockLearn more about SURGE Therapeutics IPO

Register To Buy and Sell Shares

For more details on financing and valuation for SURGE Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access SURGE Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like SURGE Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

SURGE Therapeutics investors also invested in these private companies

Khosla Ventures
8VC
Alumni Ventures
Pitango Venture Capital
KdT Ventures
Bioluminescence Ventures
Camford Capital
Intuitive Ventures
The Institute of Cancer Research

Team

Management Team

Michael Goldberg Ph.D
Founder, Chief Executive Officer & President
Charles Carignan MD
Chief Experience Officer

Board Members

Oliver Keown MD
Intuitive Ventures

Frequently Asked Questions About SURGE Therapeutics’ Stock

plusminus
Can you buy SURGE Therapeutics’ stock?
SURGE Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy SURGE Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell SURGE Therapeutics’ stock?
Yes, you can sell stock of a private company like SURGE Therapeutics. Forge can help you sell your SURGE Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is SURGE Therapeutics’ stock price?
SURGE Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access SURGE Therapeutics’ private market stock price with Forge Data.
plusminus
What is SURGE Therapeutics’ stock ticker symbol?
SURGE Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like SURGE Therapeutics in the BioTech & Pharma sector

Egenesis

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$387.57MM

Colossal Biosciences

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.01B

Prime Medicine

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.23B

ADARx Pharmaceuticals

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$827.77MM

Altos Labs

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$6.33B

Tempus

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$8.7B

Cytonics

Sector
Healthcare / BioTech & Pharma
 
 

Pendulum Therapeutics

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$308.05MM

AI Therapeutics

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$110MM

News Highlights

FORBES 07/19/2023
This Startup Just Raised $32 Million To Keep Cancers From Recurring After Surgery
On Wednesday, the company announced it has raised a $32 million series B round. The deal brings its total venture investments to $60 million. The company plans to use the new investment to continue development of its immunotherapy and to advance clinical trials for it.

Trending Companies

Frequently Asked Questions

Updated on: Apr 27, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.